Archive: valuation growth

Premium

The Third Time Is Not the Charm for This Startup

By Andy Gordon on May 12, 2022

NowRx will complete its third crowdfunding raise on SeedInvest later this month. We’ve recommended it twice. And it has worked out incredibly well for our members who invested.  But the third time is not the charm. We’re not recommending the company this time around.  So, why not? After all, NowRx continues to impress. It’s meeting its ambitious milestones and expanding…